Daniel Arias
Stock Analyst at Stifel
(5.00)
# 3
Out of 4,960 analysts
157
Total ratings
58.43%
Success rate
148.66%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $48 → $40 | $35.54 | +12.55% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $13.27 | -9.57% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $94.15 | +16.83% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $57.09 | +5.10% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $61.40 | -2.28% | 3 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $499.99 | +24.00% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $211.80 | +22.76% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $1.42 | +533.80% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $14.30 | +25.87% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $6.45 | -6.98% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,550 → $1,450 | $1,321.45 | +9.73% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $80.52 | -19.27% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $47.47 | +41.14% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $302.19 | +19.13% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $121.63 | +24.15% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $49.74 | -6.82% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.45 | +308.16% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $124.79 | +65.88% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $101.80 | +96.46% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.89 | +73.31% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.63 | +280.23% | 2 | May 31, 2022 |
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $35.54
Upside: +12.55%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $13.27
Upside: -9.57%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $94.15
Upside: +16.83%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $57.09
Upside: +5.10%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $61.40
Upside: -2.28%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $499.99
Upside: +24.00%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $211.80
Upside: +22.76%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.42
Upside: +533.80%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $14.30
Upside: +25.87%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.45
Upside: -6.98%
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,321.45
Upside: +9.73%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $80.52
Upside: -19.27%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $47.47
Upside: +41.14%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $302.19
Upside: +19.13%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $121.63
Upside: +24.15%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $49.74
Upside: -6.82%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.45
Upside: +308.16%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $124.79
Upside: +65.88%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $101.80
Upside: +96.46%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.89
Upside: +73.31%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.63
Upside: +280.23%